SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-015879
Filing Date
2024-04-25
Accepted
2024-04-25 11:37:35
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 5464
  Complete submission text file 0001493152-24-015879.txt   7001
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4908 SOUTH ASHTON COURT SPOKANE WA 99223
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31791 | Film No.: 24874115